O panorama atual da pesquisa em tratamento antiviral para monkeypox: uma análise bibliométrica da zoonose que preocupou o planeta
DOI:
https://doi.org/10.61223/coopex.v14i2.187Resumo
Introdução: Em 2022, a varíola M, zoonose semelhante à varíola convencional, foi declarada emergência de saúde pública de importância internacional pela OMS. Atualmente antivirais e vacinas são utilizados para tratamento e prevenção, embora essas estratégias sejam controversas. Objetivos: Esta revisão bibliométrica da literatura tem como objetivo medir os índices de produção e disseminação do conhecimento científico através de uma técnica quantitativa e estatística sobre o tratamento antiviral para monkeypox. Métodos: Realizou-se uma busca sistemática nas bases de pesquisa Biblioteca Virtual em Saúde (BVS) e U.S. National Library of Medicine (PubMed), utilizando os descritores "monkeypox", "antiviral agents" e "treatment", juntamente com o operador booleano "AND". Os critérios de inclusão foram publicações dos últimos 10 anos em inglês, enquanto os critérios de exclusão foram publicações repetidas entre as bases de pesquisa e artigos não relacionados ao tema. Foram selecionadas 255 publicações, das quais 79 atenderam aos critérios adequados para a pesquisa. Resultados: Com base em uma análise de natureza quantitativa das publicações, observa-se que a maioria dos artigos foi publicada entre 2022 e 2023, sendo a maior parte dos estudos publicados nos Estados Unidos, seguido do Reino Unido, Suiça, Holanda e Alemanha. O autor com o maior número de publicações é Andrew T. Russo, enquanto a revista com mais publicações é a New England Journal of Medicine. Conclusão: A média de produtividade foi de 7,9 artigos por ano. A maioria dos estudos ocorreu entre 2022 e 2023, representando 81% das publicações analisadas. Os Estados Unidos foram o país com o maior número de artigos, correspondendo a 41,7% do total (n=33). Observou-se a ausência de artigos brasileiros sobre o tema. O idioma dominante foi o inglês, conforme os critérios estabelecidos.
Referências
ADLER, H. et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. The Lancet Infectious Diseases, v. 22, n. 8, p. 1153–1162, 1 ago. 2022. Disponível em: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00228-6/fulltext. Acesso em: 13 maio 2023.
ALDHAEEFI, Mohammed; RUNGKITWATTANAKUL, Dhakrit; UNONU, Jacqueise; et al. The 2022 human monkeypox outbreak: Clinical review and management guidance. American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists, v. 80, n. 2, p. 44–52, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36259674/. Acesso em: 13 maio 2023.
ALI, Y. et al. Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus. Viruses, v. 15, n. 2, p. 570, fev. 2023. Disponível em: https://www.mdpi.com/1999-4915/15/2/570. Acesso em: 13 maio 2023.
AL-KURAISHY, H. M. et al. Monkeypox epidemic at the door: should we remain idly by or prepare strongly? AMB Express, v. 13, n. 1, p. 5, 13 jan. 2023. Disponível em: https://amb-express.springeropen.com/articles/10.1186/s13568-023-01507-0. Acesso em: 13 maio 2023.
ALMEHMADI, M. et al. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak. Viruses, v. 14, n. 9, p. 1870, 25 ago. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36146675/. Acesso em: 13 maio 2023.
AL-MUSA, Amer; CHOU, Janet; LABERE, Brenna. The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades. Clinical Immunology (Orlando, Fla.), v. 243, p. 109108, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36067982/. Acesso em: 13 maio 2023.
ANTOINE, Meghann; RUBENSTEIN, Emma; LASCOUX-COMBE, Caroline; et al. Clinical Description of Sixty-Six Cases of Monkeypox Virus (MKPV) Infection Among Men Who Have Sex With Men (MSM) in an HIV/PrEP French Clinic. Journal of Acquired Immune Deficiency Syndromes (1999), v. 92, n. 3, p. e11–e14, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36729529/. Acesso em: 13 maio 2023.
ARAÚJO, C. A. A. Bibliometria: evolução histórica e questões atuais. Em Questão, Porto Alegre, v. 12, n. 1, p. 11–32, 2006. Disponível em: https://www.seer.ufrgs.br/index.php/EmQuestao/article/view/16. Acesso em: 13 maio 2023.
BEESON, A. M. et al. Mpox in Children and Adolescents: Epidemiology, Clinical Features, Diagnosis, and Management. Pediatrics, v. 151, n. 2, p. e2022060179, 1 fev. 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36471498/. Acesso em: 13 maio 2023.
BERHANU, Aklile; PRIGGE, Jonathan T.; SILVERA, Peter M.; et al. Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection. Antimicrobial Agents and Chemotherapy, v. 59, n. 7, p. 4296–4300, 2015. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25896687/. Acesso em: 13 maio 2023.
BOJKOVA, D. et al. Drug Sensitivity of Currently Circulating Mpox Viruses. New England Journal of Medicine, v. 388, n. 3, p. 279–281, 19 jan. 2023. Disponível em: https://doi.org/10.1056/NEJMc2212136. Acesso em: 13 maio 2023.
CA, Rubio-Muniz; J, Montero-Menárguez; A, López-Valle; et al. Monkeypox: is topical cidofovir a good idea? Clinical and experimental dermatology, v. 48, n. 2, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36730511/. Acesso em: 13 maio 2023.
CARVALHO, T. The unknown efficacy of tecovirimat against monkeypox. Nature Medicine, v. 28, n. 11, p. 2224–2225, 13 set. 2022. Disponível em: https://www.nature.com/articles/d41591-022-00094-0. Acesso em: 13 maio 2023.
CASH-GOLDWASSER, S. et al. Ocular Monkeypox - United States, July-September 2022. MMWR. Morbidity and mortality weekly report, v. 71, n. 42, p. 1343–1347, 21 out. 2022. Disponível em: https://www.cdc.gov/mmwr/volumes/71/wr/mm7142e1.htm. Acesso em: 13 maio 2023.
Centers for Diseases Control and Prevention. 2022 Mpox Outbreak Global Map. Centers for Diseases Control and Prevention, 26 de abril de 2023. Disponível em https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html. Acesso em 5 de maio de 2023.
Centers for Diseases Control and Prevention, 2023. 2022 Outbreak Cases and Data. Centers for Diseases Control and Prevention, 26 de abril de 2023. Disponível em https:// www.cdc.gov/poxvirus/mpox/response/2022/index.html. Acesso em: 5 de maio de 2023.
CHAKRABORTY, Sandip; CHANDRAN, Deepak; MOHAPATRA, Ranjan K.; et al. Clinical management, antiviral drugs and immunotherapeutics for treating monkeypox. An update on current knowledge and futuristic prospects. International Journal of Surgery (London, England), v. 105, p. 106847, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35995352/. Acesso em: 13 maio 2023.
CRUMP, Ryan; KOROM, Maria; BULLER, R. Mark; et al. Buccal viral DNA as a trigger for brincidofovir therapy in the mousepox model of smallpox. Antiviral Research, v. 139, p. 112–116, 2017. Disponível em: https://pubmed.ncbi.nlm.nih.gov/28039021/. Acesso em: 13 maio 2023.
DAMMANN, F.; RAJA, M.; CAMARGO, J. F. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Transplant Infectious Disease: An Official Journal of the Transplantation Society, v. 25, n. 1, p. e14022, fev. 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36714983/. Acesso em: 13 maio 2023.
DE LA CALLE-PRIETO, Fernando; ESTÉBANEZ MUÑOZ, Miriam; RAMÍREZ, Germán; et al. Treatment and prevention of monkeypox. Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.), p. S2529-993X(22)00301-X, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36624034/. Acesso em: 13 maio 2023
DELAURENTIS, Clare E.; KISER, Jennifer; ZUCKER, Jason. New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus. Antimicrobial Agents and Chemotherapy, v. 66, n. 12, p. e0122622, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36374026/. Acesso em: 13 maio 2023.
DESAI, A. N. et al. Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection. JAMA, v. 328, n. 13, p. 1348–1350, 4 out. 2022. Disponível em: https://doi.org/10.1001/jama.2022.15336. Acesso em: 13 maio 2023.
DESHMUKH, Paulami; VORA, Agam; TIWASKAR, Mangesh; et al. Monkeypox: What do we know so far? A short narrative review of literature. The Journal of the Association of Physicians of India, v. 70, n. 7, p. 11–12, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35833402/. Acesso em: 13 maio 2023.
EARL, P. L.; AMERICO, J. L.; MOSS, B. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection. Journal of Virology, v. 91, n. 19, p. e01042-17, 12 set. 2017. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599762/. Acesso em: 13 maio 2023.
FARAHAT, R. A. et al. Monkeypox and human transmission: Are we on the verge of another pandemic? Travel Medicine and Infectious Disease, v. 49, p. 102387, 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628761/. Acesso em: 13 maio 2023.
FINAMOR, L. P. S. et al. Tecovirimat Treatment for Monkeypox Virus Keratouveitis. JAMA Ophthalmology, v. 141, n. 2, p. 210–212, 1 fev. 2023. Disponível em: https://doi.org/10.1001/jamaophthalmol.2022.5486/. Acesso em: 13 maio 2023.
FISCHER, F. et al. Monkeypox in a Patient with Controlled HIV Infection Initially Presenting with Fever, Painful Pharyngitis, and Tonsillitis. Medicina (Kaunas, Lithuania), v. 58, n. 10, p. 1409, 7 out. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36295570/. Acesso em: 13 maio 2023.
FOX, Tilly; GOULD, Susan; PRINCY, Naveena; et al. Therapeutics for treating mpox in humans. The Cochrane Database of Systematic Reviews, v. 3, n. 3, p. CD015769, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36916727/. Acesso em: 13 maio 2023.
FRENOIS-VEYRAT, G. et al. Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations. Nature Microbiology, v. 7, n. 12, p. 1951–1955, dez. 2022. Disponível em: https://www.nature.com/articles/s41564-022-01269-8. Acesso em: 13 maio 2023.
GANDHI, R. T. et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society–USA Panel. JAMA, v. 329, n. 1, p. 63–84, 3 jan. 2023. Disponível em: https://doi.org/10.1001/jama.2022.22246. Acesso em: 13 maio 2023.
GOMES, D.; STAVROPOULOU, C. The impact generated by publicly and charity-funded research in the United Kingdom: a systematic literature review. Health Research Policy and Systems, v. 17, n. 1, p. 22, 28 fev. 2019. Disponível em: https://doi.org/10.1186/s12961-019-0425-2/. Acesso em: 13 maio 2023.
GROSENBACH, D. W. et al. Oral Tecovirimat for the Treatment of Smallpox. New England Journal of Medicine, v. 379, n. 1, p. 44–53, 5 jul. 2018. Disponível em: https://doi.org/10.1056/NEJMoa1705688. Acesso em: 13 maio 2023.
GROSENBACH, D. W.; HRUBY, D. E. Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals. Methods in Molecular Biology (Clifton, N.J.), v. 2023, p. 143–155, 2019. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31240676/. Acesso em: 13 maio 2023.
HAEFLIGER, D.; LIVIO, F. [Pharmacotherapy: New drugs and vaccines in 2022]. Revue Medicale Suisse, v. 19, n. N° 809-10, p. 66–73, 18 jan. 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36660841/. Acesso em: 13 maio 2023.
HALANI, Sheliza; LEONG, Derek; WU, Peter E. Tecovirimat for monkeypox. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne, v. 194, n. 46, p. E1573, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36442878/. Acesso em: 13 maio 2023.
HERNANDEZ, L. E.; JADOO, A.; KIRSNER, R. S. Human monkeypox virus infection in an immunocompromised man: trial with tecovirimat. The Lancet, v. 400, n. 10355, p. e8, 10 set. 2022. Disponível em: https://www.thelancet.com/article/S0140-6736(22)01528-8/fulltext. Acesso em: 13 maio 2023.
HUANG, Y. A. et al. Monkeypox: A clinical update for paediatricians. Journal of Paediatrics and Child Health, v. 58, n. 9, p. 1532–1538, set. 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545589/. Acesso em: 13 maio 2023.
HUNG, Y.-P. et al. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. Journal of Microbiology, Immunology, and Infection, v. 55, n. 5, p. 795–802, out. 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521168/. Acesso em: 13 maio 2023.
HUTSON, C. L. et al. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model. mSphere, v. 6, n. 1, p. e00927-20, 3 fev. 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33536322/. Acesso em: 13 maio 2023.
KABANOV, A. S. et al. [A comparative study of the antiviral activity of chemical compounds concerning the orthopoxviruses experiments in vivo]. Voprosy Virusologii, v. 58, n. 4, p. 39–43, 2013. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24354064/. Acesso em: 13 maio 2023.
KARAGOZ, Aysel; TOMBULOGLU, Huseyin; ALSAEED, Moneerah; et al. Monkeypox (mpox) virus: Classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis. Journal of Infection and Public Health, v. 16, n. 4, p. 531–541, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36801633/. Acesso em: 13 maio 2023.
KARIM, Asad Mustafa; KWON, Jeong Eun; KARIM, Mujahid Aizaz; et al. Comprehensive update on the monkeypox outbreak. Frontiers in Microbiology, v. 13, p. 1037583, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36439787/. Acesso em: 13 maio 2023.
KHAN, Madiha; RAHMAN, Syed; AHMED, Fahad; et al. Managing Monkeypox Virus: Characterizing Common Cutaneous Manifestations and Antiviral Efficacy. Journal of drugs in dermatology: JDD, v. 22, n. 3, p. 282–287, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36877881/. Acesso em: 13 maio 2023.
KHANI, Elnaz; AFSHARIRAD, Bentelhoda; ENTEZARI-MALEKI, Taher. Monkeypox treatment: Current evidence and future perspectives. Journal of Medical Virology, v. 95, n. 1, p. e28229, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36253931/. Acesso em: 13 maio 2023.
KOWALSKI, J. et al. Study of the first clinical cases on monkeypox in Poland. Przeglad Epidemiologiczny, v. 76, n. 2, p. 168–183, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36217881/. Acesso em: 13 maio 2023.
KURODA, Naoto; SHIMIZU, Tadashi; HIRANO, Daishi; et al. Lack of clinical evidence of antiviral therapy for human monkeypox: A scoping review. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy, v. 29, n. 2, p. 228–231, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36283609/. Acesso em: 13 maio 2023.
LABATE, Laura; BRUCCI, Giorgia; CICCARESE, Giulia; et al. Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV. International journal of STD & AIDS, v. 34, n. 3, p. 208–210, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36520997/. Acesso em: 13 maio 2023.
LAI, Chih-Cheng; HSU, Chi-Kuei; YEN, Muh-Yong; et al. Monkeypox: An emerging global threat during the COVID-19 pandemic. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi, v. 55, n. 5, p. 787–794, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35970757/. Acesso em: 13 maio 2023.
LONG, Brit; KOYFMAN, Alex; GOTTLIEB, Michael; et al. Monkeypox: A focused narrative review for emergency medicine clinicians. The American Journal of Emergency Medicine, v. 61, p. 34–43, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35970757/. Acesso em: 13 maio 2023.
LUCAR, Jose; ROBERTS, Afsoon; SAARDI, Karl M.; et al. Monkeypox Virus-Associated Severe Proctitis Treated With Oral Tecovirimat: A Report of Two Cases. Annals of Internal Medicine, v. 175, n. 11, p. 1626–1627, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35981225/. Acesso em: 13 maio 2023.
MBRENGA, F. et al. Tecovirimat for Monkeypox in Central African Republic under Expanded Access. New England Journal of Medicine, v. 387, n. 24, p. 2294–2295, 15 dez. 2022. Disponível em: https://doi.org/10.1056/NEJMc2210015. Acesso em: 13 maio 2023.
MEDEIROS, G.et al. Análise da segurança e eficácia dos medicamentos antivirais para o tratamento da varíola dos macacos: uma revisão integrativa: Analysis of the safety and efficacy of antiviral drugs for the treatment of monkeypox: an integrative review. Revista Coopex., v. 14, n. 1, p. 159–178, 25 jan. 2023. Disponível em: https://coopex.unifip.edu.br/index.php/coopex/article/view/113. Acesso em: 13 maio 2023.
MITJÀ, O. et al. Monkeypox. The Lancet, v. 401, n. 10370, p. 60–74, 7 jan. 2023. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02075-X/fulltext. Acesso em: 13 maio 2023.
MONDI, Annalisa; GAGLIARDINI, Roberta; MAZZOTTA, Valentina; et al. Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital. The Journal of Infection, v. 86, n. 1, p. 66–117, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36347428/. Acesso em: 13 maio 2023.
MOSCHESE, D. et al. Hospitalisation for monkeypox in Milan, Italy. Travel Medicine and Infectious Disease, v. 49, p. 102417, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35934310/. Acesso em: 13 maio 2023.
NADAR, Sahaya; KHAN, Tabassum; OMRI, Abdelwahab. Reemergence of monkeypox: prevention and management. Expert Review of Anti-Infective Therapy, v. 20, n. 11, p. 1425–1433, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36161803/. Acesso em: 13 maio 2023.
O’LAUGHLIN, K. et al. Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol - United States, May-August 2022. MMWR. Morbidity and mortality weekly report, v. 71, n. 37, p. 1190–1195, 16 set. 2022. Disponível em: https://europepmc.org/article/med/36107794. Acesso em: 13 maio 2023.
O’MALLEY, Patricia Anne. Antiviral Considerations for Monkeypox Infection - USE CAUTION! Clinical nurse specialist CNS, v. 37, n. 1, p. 9–10, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36508228/. Acesso em: 13 maio 2023.
OBEID, M. A. et al. Monkeypox: Emerging virus of concern; antivirals and vaccines therapeutic options. Microbial Pathogenesis, v. 173, n. Pt A, p. 105799, dez. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36182078/. Acesso em: 13 maio 2023.
PHILPOTT, D. et al. Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022. Morbidity and Mortality Weekly Report, v. 71, n. 32, p. 1018–1022, 12 ago. 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400536/. Acesso em: 13 maio 2023.
RABAAN, Ali A.; ABAS, Abdul Hawil; TALLEI, Trina Ekawati; et al. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. Journal of Medical Virology, v. 95, n. 1, p. e28306, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36372558/. Acesso em: 13 maio 2023.
RACCAGNI, Angelo Roberto; CANDELA, Caterina; BRUZZESI, Elena; et al. Real-life use of cidofovir for the treatment of severe monkeypox cases. Journal of Medical Virology, v. 95, n. 1, p. e28218, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36229902/. Acesso em: 13 maio 2023.
RAMDASS, P.; MULLICK, S.; FARBER, H. F. Viral Skin Diseases. Primary Care: Clinics in Office Practice, Primary Care Dermatology. v. 42, n. 4, p. 517–567, 1 dez. 2015. Disponível em: https://www.sciencedirect.com/science/article/pii/S0095454315000755. Acesso em: 13 maio 2023.
REINA, J.; REINA, N. Should we be already worried about Monkeypox? Medicina Clinica, v. 151, n. 8, p. 320–322, 23 out. 2018. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29747868/. Acesso em: 13 maio 2023.
RIZK, John G.; LIPPI, Giuseppe; HENRY, Brandon M.; et al. Prevention and Treatment of Monkeypox. Drugs, v. 82, n. 9, p. 957–963, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35763248/. Acesso em: 13 maio 2023.
RODRÍGUEZ-MORALES, A. J.; ORTIZ-MARTÍNEZ, Y.; BONILLA-ALDANA, D. K. What has been researched about monkeypox? a bibliometric analysis of an old zoonotic virus causing global concern. New Microbes and New Infections, v. 47, p. 100993, 1 abr. 2022. https://www.sciencedirect.com/science/article/pii/S2052297522000452/. Acesso em: 13 maio 2023.
RUIZ-PACHECO, J. A. et al. Diabetes mellitus: Lessons from COVID-19 for monkeypox infection. Primary Care Diabetes, v. 17, n. 2, p. 113–118, abr. 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36737358/. Acesso em: 13 maio 2023.
RUSSO, A. T. et al. Co-administration of tecovirimat and ACAM2000TM in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine, v. 38, n. 3, p. 644–654, 16 jan. 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31677948/. Acesso em: 13 maio 2023.
RUSSO, Andrew T.; GROSENBACH, Douglas W.; BRASEL, Trevor L.; et al. Effects of Treatment Delay on Efficacy of Tecovirimat Following Lethal Aerosol Monkeypox Virus Challenge in Cynomolgus Macaques. The Journal of Infectious Diseases, v. 218, n. 9, p. 1490–1499, 2018. Disponível em: https://pubmed.ncbi.nlm.nih.gov/29982575/. Acesso em: 13 maio 2023.
RUSSO, Andrew T.; GROSENBACH, Douglas W.; CHINSANGARAM, Jarasvech; et al. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Review of Anti-Infective Therapy, v. 19, n. 3, p. 331–344, 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32882158/. Acesso em: 13 maio 2023.
SABEENA, Sasidharanpillai. The changing epidemiology of monkeypox and preventive measures: an update. Archives of Virology, v. 168, n. 1, p. 31, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36604361/. Acesso em: 13 maio 2023.
SALCEDO, Ricardo M.; MADARIAGA, Miguel G. Monkeypox (hMPXV Infection): A Practical Review. The American Journal of Medicine, v. 136, n. 3, p. 234–243, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36495937/. Acesso em: 13 maio 2023.
SERGEEV, A. A. et al. The Possibility of Using the ICR Mouse as an Animal Model to Assess Antimonkeypox Drug Efficacy. Transboundary and Emerging Diseases, v. 63, n. 5, p. e419-430, out. 2016. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25597343/. Acesso em: 13 maio 2023.
SERGEEV, A. A. et al. Using the Ground Squirrel (Marmota bobak) as an Animal Model to Assess Monkeypox Drug Efficacy. Transboundary and Emerging Diseases, v. 64, n. 1, p. 226–236, fev. 2017. Disponível em: https://pubmed.ncbi.nlm.nih.gov/25944444/. Acesso em: 13 maio 2023.
SHAMIM, Muhammad Aaqib; PADHI, Bijaya Kumar; SATAPATHY, Prakasini; et al. The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases, v. 127, p. 150–161, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36470502/. Acesso em: 13 maio 2023.
SHERWAT, A. et al. Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations. The New England Journal of Medicine, v. 387, n. 7, p. 579–581, 18 ago. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35921403/. Acesso em: 13 maio 2023.
SIEGRIST, Emily A.; SASSINE, Joseph. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, v. 76, n. 1, p. 155–164, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35904001/. Acesso em: 13 maio 2023.
SILVA, L. A. DA et al. Pandemias e suas repercussões sociais ao longo da história associado ao novo SARS-COV-2: Um estudo de revisão. Research, Society and Development. v. 10, n. 3, 2021. Disponível em: https://ninho.inca.gov.br/jspui/handle/123456789/11235. Acesso em: 13 maio 2023.
SINGHAL, Tanu; KABRA, S. K.; LODHA, Rakesh. Monkeypox: A Review. Indian Journal of Pediatrics, v. 89, n. 10, p. 955–960, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35947269/. Acesso em: 13 maio 2023.
SMEE, Donald F. Orthopoxvirus inhibitors that are active in animal models: an update from 2008 to 2012. Future Virology, v. 8, n. 9, p. 891–901, 2013. Disponível em: https://pubmed.ncbi.nlm.nih.gov/24563659/. Acesso em: 13 maio 2023.
SOHEILI, M. et al. Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments. Journal of Pharmacy & Pharmaceutical Sciences: A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, v. 25, p. 297–322, 2022. Disponível em: https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/33138. Acesso em: 13 maio 2023.
SUDARMAJI, N. et al. Prevention and Treatment of Monkeypox: A Systematic Review of Preclinical Studies. Viruses, v. 14, n. 11, p. 2496, 11 nov. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36423105/. Acesso em: 13 maio 2023.
SUKHDEO, Sharon; MISHRA, Sharmistha; WALMSLEY, Sharon. Human monkeypox: a comparison of the characteristics of the new epidemic to the endemic disease. BMC infectious diseases, v. 22, n. 1, p. 928, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36503476/. Acesso em: 13 maio 2023.
UPADHAYAY, Shubham; ARTHUR, Richmond; SONI, Divya; et al. Monkeypox infection: The past, present, and future. International Immunopharmacology, v. 113, n. Pt A, p. 109382, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36330915/. Acesso em: 13 maio 2023.
VASQUEZ-PEREZ, A. et al. Necrotizing Blepharoconjunctivitis and Keratitis in Human Monkeypox. JAMA Ophthalmology, v. 141, n. 3, p. 285–288, 1 mar. 2023. Disponível em: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2801308. Acesso em: 13 maio 2023.
VIVANCOS, R. et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance, v. 27, n. 22, p. 2200422, 2 jun. 2022. Disponível em: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.22.2200422. Acesso em: 13 maio 2023.
WARNER, B. M. et al. In vitro and in vivo efficacy of tecovirimat against a recently emerged 2022 monkeypox virus isolate. Science Translational Medicine, v. 14, n. 673, p. eade7646, 30 nov. 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36318038/. Acesso em: 13 maio 2023.
WEBB, E. et al. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review. BMJ Global Health, v. 7, n. 8, p. e009838, 5 ago. 2022. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472169/. Acesso em: 13 maio 2023.
World Health Organization. WHO Director-General declares the ongoing monkeypox outbreak a Public Health Emergency of International Concern. World Health Organization, 23 de julho de 2022. Disponível em: < www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern> Acesso 5 de maio de 2023.
ZOVI, Andrea; FERRARA, Francesco; LANGELLA, Roberto; et al. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. International Journal of Molecular Sciences, v. 23, n. 24, p. 15941, 2022. Disponível em: https://pubmed.ncbi.nlm.nih.gov/36555584/. Acesso em: 13 maio 2023.
Downloads
Publicado
Como Citar
Licença
Copyright (c) 2023 Gabriel Medeiros, Ana Caroliny de Aquino, Bruna Olegário, Luiz Medeiros, Everson Santos
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons 
.png){kind=logo}
